Regulation of myocardial fibrillar collagen by angiotensin II. A role in hypertensive heart disease?

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 12, 2002, Pages 1585-1593

  González, Arantxa ^a   López, Begoña ^a   Querejeta, Ramón ^b   Díez, Javier ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

Author keywords

Angiotensin II; Arterial hypertension; Collagen; Fibrosis; Myocardium

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANGIOTENSIN II; FIBRILLAR COLLAGEN;

CELL FUNCTION; COLLAGEN SYNTHESIS; FIBROBLAST; HEART DISEASE; HUMAN; HYPERTENSION; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS REGULATION; REVIEW; FIBROSIS; HEART MUSCLE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANGIOTENSIN II; ANTIHYPERTENSIVE AGENTS; FIBRILLAR COLLAGENS; FIBROSIS; HUMANS; HYPERTENSION; MYOCARDIUM;

EID: 0036903352     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2002.2081     Document Type: Article

References (80)

1. van der Rest M, Bruckner P. Collagens: Diversity at the molecular and supramolecular levels. Curr Opin Struct Biol 1993; 3: 430-436.
2. Miller EJ, Gay S. Collagen: An overview. Methods Enzymol 1982; 82: 3-32.
3. van der Rest M, Garrone R. Collagen family of proteins. FASEB J 1991; 5: 2814-2823.
4. Koch M, Foley JE, Hahn R, Zhou P, Burgeson RE, Gerecke DR, Gordon MK. Alpha 1 (XX) collagen, a new member of the collagen subfamily, fibril-associated collagens with interrupted triple helices. J Biol Chem 2001; 276: 23120-23126.
5. Vuorio E, de Crombrugghe B. The family of collagen genes. Ann Rev Biochem 1990; 59: 837-872.
6. Booz GW, Baker KM. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res 1995; 30: 537-543.
7. Kivirkko K, Myllyla R. Recent developments in post-translational modification: Intracellular processing. Meth Enzymol 1987; 144: 96-114.
8. Fleischmajer R, Perlish JS. The role of the amino propeptide in collagen fibrillogenesis. Rheumatology 1986; 10: 91-103.
9. Jensen LT, Risteli J, Nielsen MD, Henriksen JH, Olesen HP, Risteli L, Lorenzen I. Purification of porcine aminoterminal propeptide of type III procollagen from lymph and use for lymphatic clearance studies in pigs. Matrix 1992; 11: 73-79.
10. Risteli J, Risteli L. Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol 1995; 22 (Suppl. 2): 77-81.
11. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: Biological consequences. Curr Opin Cell Biol 1998; 10: 602-608.
12. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM. Tissue inhibitor of metalloproteinases (TIMP aka EPA): Structure, control of expression and biological functions. Pharmacol Ther 1993; 59: 329-341.
13. McAnulty RJ, Laurent GJ. Collagen synthesis and degradation in vivo. Evidence for rapid rates of collagen turnover with extensive degradation of newly synthesized collagen in tissues of the adult rat. Coll Relat Res 1987; 7: 93-104.
14. Laurent GJ. Dynamic state of collagen: Pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 1987; 252: C1-C9.
15. Sun Y, Weber KT. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 1996; 28: 851-858.
16. Sappino AP, Schuerch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990; 63: 144-161.
17. Vracko R, Thorning D. Contractile cells in rat myocardial scar tissue. Lab Invest 1991; 65: 214-227.
18. Petrov VV, Eagard RH, Lijnen PJ. Stimulation of collagen production by transforming growth factorβ1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 2002; 39: 258-263.
19. Katwa LC, Campbell SE, Tyagi SC, Lee SJ, Cicila GT, Weber KT. Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol 1997; 29: 1375-1386.
20. Medugorac I. Characterization of intramural collagen in the mammalian left ventricle. Basic Res Cardiol 1982; 77: 589-598.
21. Mukherjee D, Sen S. Alteration of collagen phenotypes in ischemic cardiomyopathy. J Clin Invest 1991; 88: 1141-1146.
22. Eghbali M, Czaja MJ, Zeydel M, Weiner FR, Zern MA, Seifter S, Blumenfeld OO. Collagen mRNAs in isolated adult heart cell. J Mol Cell Cardiol 1988; 20: 267-276.
23. Eghbali M, Blumenfeld OO, Seifter S, Buttrick PM, Leinwand LA, Robinson TF, Zern MA, Giambrone MA, Localization of types I, III and IV collagen mRNAs in rat heart cells by in situ hybridization. J Mol Cell Cardiol 1989; 21: 103-113.
24. McAnulty RJ, Laurent GJ. Collagen synthesis and degradation in vivo. Evidence for rapid rates of collagen turnover with extensive degradation of newly synthesized collagen in tissues of the adult rat. Collagen Relat Res 1987; 7: 93-104.
25. Monfort I, Perez-Tamayo R. The distribution of collagenase in normal rat tissues. J Histochem Cytochem 1975; 23: 910-920.
26. Cleutjens JPM, Kandala JC, Guarda E, Guntaka RV, Weber KT. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 1994; 27: 1281-1292.
27. Coker MS, Thomas CV, Doscher MA. Matrix metalloproteinase expression and activity in adult ventricular myocytes: Influence of basement membrane adhesion. Circulation 1997; 96: I-689. Abstract.
28. Tyagi SC, Matsubara L, Weber KT. Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem 1993; 26: 191-198.
29. Weber KT. Angiotensin II and connective tissue: Homeostasis and reciprocal regulation. Regul Pept 1999; 82: 1-17.
30. Burlew BS, Weber KT. Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin 2000; 18: 435-442.
31. Weber KT. Cardiac interstitium in health and disease: The fibrillar collagen network. J Am Coll Cardiol 1989; 13: 1637-1652.
32. Terracio L, Rubin T, Gullberg D, Balog ED, Carver W, Jyring R, Borg TK. Expression of collagen binding integrins during cardiac development and hypertrophy. Circ Res 1991; 68: 734-744.
33. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ Res 1993; 73: 413-423.
34. Zhou G, Kandala JC, Tyagi SC, Katwa LC, Weber KT. Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem 1996; 154: 171-178.
35. 1, thyroid hormone, angiotensin II and basic fibroblasts growth factor. J Mol Cell Cardiol 1997; 29: 2233-2244.
36. Hafizi S, Wharton J, Morgan K, Allen SP, Chester AH, Catravas JD, Polak JM, Yacoub MH. Expression of functional angiotensin-converting enzyme and AT1 receptors in cultured human cardiac fibroblasts. Circulation 1998; 98: 2553-2559.
37. Staufenberger S, Jacobs M, Brandstatter K, Hafner M, Regitz-Zagrosek V, Ertl G, Schorb W. Angiotensin II type I receptor regulation and differential trophic effects on rat cardiac myofibroblasts after acute myocardial infarction. J Cell Phgsiol 2001; 187: 326-335.
38. Weber KT, Sun Y, Katwa LC. Myofibroblasts and local angiotensin II in rat cardiac tissue repair. Int J Biochem Cell Biol 1997; 29: 31-42.
39. Bouzegrhane F, Thibault G. Is angiotensin II a proliferative factor of cardiac fibroblasts? Cardiovasc Res 2002; 53: 304-312.
40. Schnee JM, Hsueh WA. Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc Res 2000; 46: 264-268.
41. Dostal DE, Booz GW, Baker KM. Angiotensin II signalling pathways in cardiac fibroblasts: Conventional versus novel mechanisms in mediating cardiac growth and function. Mol Cell Biochem 1996; 157: 15-21.
42. Tharaux PL, Chatziantoniou C, Fakhouri E, Dussaule JC. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension 2000; 36: 330-336.
43. Ghiggeri GM, Oleggini R, Musante L, Garidi G, Gusmano R, Ravazzolo R. A DNA element in the α1 type III collagen promoter mediates a stimulatory response by angiotensin II. Kidney Int 2000; 58: 537-548.
44. Dostal DE. Regulation of cardiac collagen. Angiotensin and cross-talk with local growth factors. Hypertension 2001; 37: 841-844.
45. Hao J, Wang B, Jones SC, Jassal DS, Dixon IM. Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am J Physiol 2000; 279: H3020-H3030.
46. Pathak M, Sarkar S, Vellaichamy E, Sen S. Role of myocytes in myocardial collagen production. Hypertension 2001; 37: 833-840.
47. Leipala JA, Takala TE, Ruskoaho H, Myllyla R, Kainulainen H, Hassinen IE, Anttinen H, Vihko V. Transmural distribution of biochemical markers of total protein and collagen synthesis, myocardial contraction speed and capillary density in the rat left ventricle in angiotensin II-induced hypertension. Acta Physiol Scand 1988; 133: 325-333.
48. Ju H, Zhao S, Jassal DS, Dixon IM. Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction. Cardiovasc Res 1997; 35: 223-232.
49. Funck RC, Wilke A, Rupp H, Brilla CG. Regulation and role of myocardial matrix remodeling in hypertensive heart disease. Adv Exp Mol Biol 1997; 432: 35-44.
50. Chua CH, Hamdy RC, Chua BH. Angiotensin II induces TIMP-1 production in rat heart endothelial cells. Biochem Biophys Acta 1996; 1311: 175-180.
51. Ohkubo N, Matsubara H, Nozawa Y, Mori Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Tsutumi Y, Shibazaki Y, Iwasaka T, Inada M. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 1997; 96: 3954-3962.
52. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. Effects of angiotensinconverting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: Role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997; 99: 1926-1935.
53. Brilla CG, Zhou G, Rupp H, Maisch B, Weber KT. Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol 1995; 76: 8D-13D.
54. Ichihara S, Senbonmatsu T, Price E Jr, Ichiki T, Gaffney FA, Inagami T. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 2001; 104: 346-351.
55. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999; 79: 215-262.
56. Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: Functional significance and regulatory factors. Cardiovasc Res 1993; 27: 341-348.
57. Frohlich ED. Fibrosis and ischemia: The real risks in hypertensive heart disease. Am J Hypertens 2001; 14: 194S-199S.
58. Diez J, Lopez B, Gonzalez A, Querejeta R. Clinical aspects of hypertensive myocardial fibrosis. Curr Opin Cardiol 2001; 16: 328-335.
59. Bishop JE, Lindhal G. Regulation of cardiovascular collagen synthesis by mechanical load. Cardiovase Res 1999; 42: 27-44.
60. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the right and left ventricle in experimental hypertension. Circ Res 1990; 67: 1355-1364.
61. Sun Y, Ramires FJA, Weber KT. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 1997; 35: 138-147.
62. Panizo A, Pardo J, Hernandez M, Galindo MF, Cenarruzabeitia E, Diez J. Quinapril decreases myocardial accumulation of extracellular matrix in spontaneously hypertensive rats. Am J Hypertens 1995; 8: 815-822.
63. 1 blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats. Hypertension 2000; 35: 1197-1202.
64. Olivetti G, Melissari M, Balbi T, Quainin F, Cigola E, Sonnenblick EH, Anversa P. Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure. Cardiovasc Res 1994; 28: 1199-1208.
65. Amanuma S, Sekiguchi M, Ogasawara S, Honda M, Hosooa S. Biventricular endomyocardial biopsy findings in essential hypertension of graded severity. Postgrad Med J 1994; 70: S67-S71.
66. Pearlman ES, Weber KT, Janicki JS, Pietra GG, Eishman AP. Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest 1982; 46: 158-164.
67. Weber KT, Fibrosis and hypertensive heart disease. Curr Opin Cardiol 2000; 15: 264-272.
68. Jalil JE, Janicki JS, Pick R, Weber KT. Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension: Response to captopril. Am J Hypertens 1991; 4: 51-55.
69. Sun Y, Ratajska A, Zhou G, Weber KT. Angiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J Lab Clin Med 1993; 122: 395-403.
70. Ratajska A, Campbell SE, Cleutjens JPM, Weber KT. Angiotensin II and structural remodeling of coronary vessels in rats. J Lab Clin Med 1994; 124: 408-415.
71. Everett AD, Tufro-McReddie A, Fisher A, Gomez RA, Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-β1 expression. Hypertension 1994; 23: 587-592.
72. Campbell JE, Janicki JS, Weber KT. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol 1995; 27: 1545-1560.
73. Hinglais N, Heudes D, Nicoletti A, Mandet C, Laurent M, Bariety J, Zimmerman A, Corman B. Colocalization of myocardial fibrosis and inflammatory cells in rats. Lab Invest 1994; 70: 286-294.
74. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H. Angiotensin II-induced cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 1995; 25: 1252-1259.
75. Crawford DC, Chobanian AV, Brecher P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res 1994; 74: 727-739.
76. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991; 83: 1771-1779.
77. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991; 69: 107-115.
78. Varo N, Etayo JC, Zalba G, Beaumont J, Iraburu MJ, Montiel C, Gil MJ, Monreal I, Diez J. Losartan inhibits the posttranslational synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats. J Hypertens 1999; 17: 107-114.
79. Brilla CG, Funck RC, Rupp RH. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000; 102: 1388-1393.
80. Lopez B, Querejeta R, Varo N, Gonzalez A, Larman M, Martinez Ubago JL, Diez J. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 2001; 104: 286-291.